Cancyt 100mg Injection

About

Cancyt 100mg Injection is a cytotoxic chemotherapy agent used in the treatment of various cancers. It works by interfering with DNA synthesis and repair, leading to cell cycle arrest and programmed cell death in rapidly dividing cancer cells. This mechanism helps to inhibit tumor growth and reduce the spread of malignant cells throughout the body, making it an effective treatment option for several types of solid tumors.

As an antimetabolite, Cancyt is often incorporated into combination chemotherapy regimens to enhance its efficacy and overcome resistance. Its administration requires careful monitoring of hematological parameters due to its potential for myelosuppression, ensuring patient safety throughout the treatment course.

Uses

• Treatment of pancreatic cancer
• Treatment of non-small cell lung cancer
• Treatment of breast cancer
• Treatment of ovarian cancer

Directions For Use

Cancyt 100mg Injection is administered intravenously by a healthcare professional. Dosage and schedule are determined by the patient's condition, body surface area, and specific cancer protocol.

Benefits

• Effective against a range of solid tumors
• Can be used as monotherapy or in combination regimens
• May improve survival rates in certain cancers
• Relatively well-tolerated compared to some other chemotherapies
• Can help manage disease progression
• Established efficacy in clinical practice

Side Effects

• Myelosuppression (low blood counts: neutropenia, thrombocytopenia, anemia)
• Nausea
• Vomiting
• Fatigue
• Fever
• Rash
• Hair loss (alopecia)
• Flu-like symptoms
• Edema (swelling)
• Elevated liver enzymes
• Proteinuria (protein in urine)
• Dyspnea (shortness of breath)

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate gastrointestinal side effects and potentially interact with the medication.
• Pregnancy - Contraindicated in pregnancy due to significant risk of fetal harm. Effective contraception is essential.
• Breastfeeding - Not recommended during breastfeeding as the drug may pass into breast milk and harm the infant.
• Liver - Use with caution in patients with pre-existing liver impairment; monitor liver function tests closely.
• Kidney - Use with caution in patients with pre-existing kidney impairment; monitor renal function tests closely and adjust dose if necessary.
• Lung - Monitor for pulmonary toxicity, including interstitial pneumonitis and acute respiratory distress syndrome, especially in patients with pre-existing lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.